I teach in this [CNBC Investing Club] that there's a difference, and most people don't seem to know the difference, so we have to teach." BioNano Genomics: "There's not much there, and you know what, it's a good spec. I actually like [CRISPR Therapeutics]. I do. I'm not ...
While my stock category preferences and individual sticks might not be a good fit for you, I really recommend taking the time to think about what excites you and whether you even want to be hands-on at all with your stock investments. If you have zero interest in stock picking and monitor...
The auctions are of interest to stock investors as well. That’s because art sales, although not a direct proxy for the “real” economy, correlate strongly with other important indicators. Robust sales are a sign that the world’s wealthiest people feel bullish about the economy, something th...
Before you buy stock in Vertex Pharmaceuticals, consider this: TheMotley Fool Stock Advisoranalyst team just identified what they believe are the10 best stocksfor investors to buy now… and Vertex Pharmaceuticals wasn’t one of them. The 10 stocks that made the cut could produce monster ...
“Our technology amplifies the signal to express more proteins for longer while at the same time effectively eliminating the mRNA’s off-target expression,” Strand CEO Jacob Becraft PhD ’19 explains. Credit: MIT News, iStock MITspinout Strand Therapeutics has developed a new class of mRNA mol...
Alan Safahi is a serial entrepreneur with 30+ years of experience in the information technology, telecommunications and fintech segments.
maniculatus bairdiireference genome (top).e, Profile alignment for a portion of the N-terminal region (Muspositions 105–125 a.a.) of HOXD13 inPeromyscus, other rodents and human.f, Left: examples of transgenicMuswild type and homozygous for the engineeredHoxd13CRISPR allele (109Ala) ...
(2) The discovery of CRISPR was a first step to humans being able to reprogram ourselves – a step as seminal as any. And yet, I appreciated the thoughtfulness with which the scientists involved proceeded. They attempted to continue to experiment while ensuring there was an ongoing conversation...
exacerbation. From the digital medical record, demographic and medical data were abstracted, in addition to Ottawa COPD threat Score (OCRS) ended up being calculated for each. Short-term serious outcomes (SSO) included ICU admission, intubation, myocardial infarction, non-invasive good stress air ...
“crispr definitely has off-targets. but a lot of people use it assuming no other mutations get introduced during the process,” he says. “so getting people to talk about the need for controls is a good outcome of this whole thing.” and while he was surprised by the lack of some ...